Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-17

FDA Approved: DEFERASIROX — Supplemental Application (Dr. Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' supplemental application for deferasirox (generic) under the approved labeling for chronic iron overload due to blood tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)

Snippet

SUPPL AP for DEFERASIROX (DEFERASIROX)